Literature DB >> 7684376

Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor.

M Hayakawa1, N Ishida, K Takeuchi, S Shibamoto, T Hori, N Oku, F Ito, M Tsujimoto.   

Abstract

The role of phospholipase A2 (PLA2) in the cytotoxic action of tumor necrosis factor (TNF) was examined. Recently, we described the characterization of TNF-resistant sublines isolated from TNF-sensitive cell line L929 (Hayakawa, M., Oku, N., Takagi, T., Hori, T., Shibamoto, S., Yamanaka, Y., Takeuchi, K., Tsujimoto, M., and Ito, F. (1991) Cell Struct. Funct. 16, 333-340). The most remarkable features of these TNF-resistant sublines were the defects in TNF-stimulated arachidonate metabolism. In this study, we characterized the PLA2 activities of these sublines and found a significant decrease in the activity in one of the TNF-resistant sublines, C12 cells. The enzymological features, such as Ca2+ requirement and substrate specificity, suggested that the high molecular weight arachidonoyl-selective cytosolic PLA2 (cPLA2) was involved in the TNF action. Northern hybridization analysis demonstrated the reduced expression of high molecular weight cPLA2 in C12 cells. Furthermore, expression of a cloned cPLA2 cDNA in C12 cells increased the sensitivity of cells to the TNF cytotoxicity. These results indicate the crucial role of the high molecular weight cPLA2 in the TNF-induced cytolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684376

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.

Authors:  L Foghsgaard; M Jäättelä
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.

Authors:  M Higuchi; B B Aggarwal; E T Yeh
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.

Authors:  Yukio Saito; Kazuhiro Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Jun-ei Obata; Kenichi Kawabata; Yosuke Watanabe; Hideto Mishina; Shun Tamaru; Yoshihiro Kita; Takao Shimizu; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

5.  Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective.

Authors:  Scott D Williams; Roberta A Gottlieb
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 6.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain.

Authors:  V B O'Donnell; S Spycher; A Azzi
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis.

Authors:  R U Jänicke; X Y Lin; F H Lee; A G Porter
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.